
Healthcare / Pharmaceuticals · NSE
Ambey Laboratories, incorporated in 1985, is a leading agrochemical manufacturer specializing in crop protection solutions and has been a key player in the industry for nearly four decades. Operating from its ISO 9001:2015 and ISO 14001:2015 certified facility in Behror, Rajasthan, the company is renowned for producing and supplying 2,4-D base chemicals and a diverse range of agrochemical formulations, including herbicides, insecticides, and fungicides. Its product portfolio features 2,4-D Acid 98% TC, 2,4-D Sodium 95% SP, 2,4-D Amine, Chlorpyriphos, Thiamethoxam, Pretilachlor, Metribuzin, Hexaconazole, and Metalaxyl, among others, catering to domestic and international markets. With a workforce of 220 employees as of October 31, 2023, Ambey Laboratories serves prominent corporate clients such as Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd., reinforcing its position as a trusted supplier in the agrochemical sector.
Price Band
₹65 – ₹68
Issue Size
₹44.68 Cr
Lot Size
2000 shares
GMP
+41.2%
Est. Listing
₹96
at current GMP
Subscribed
159.71x
overall
Open
4 Jul 2024
Close
8 Jul 2024
Allotment
9 Jul 2024
Refund
10 Jul 2024
Demat Credit
11 Jul 2024
Listing
11 Jul 2024
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹68
Band: ₹65 – ₹68
Estimated Listing Price
₹96
Upper price + GMP
Lot Size
2000 shares
Min investment ₹1,36,000
Estimated Profit / Lot
₹56,000
2000 × ₹28
Grey Market Premium trend
+₹28
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹28 | 41.2% | ₹96 |
| 30 Oct 2026 | +₹28 | 41.2% | ₹96 |
| 29 Oct 2026 | +₹25 | 37.1% | ₹93 |
GMP is unofficial market data. Not a guarantee of listing performance.
Ambey Laboratories Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹44.68 Crores. The shares are offered at a price band of ₹65 to ₹68 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2024-07-08, the basis of allotment is scheduled to be finalized on 2024-07-09. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.
The latest grey market premium for Ambey Laboratories Limited IPO is ₹28, which indicates an expected listing price of ₹96.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.